/

Dyno Therapeutics

Designs AI-powered AAV vectors for targeted gene therapy delivery.

BiotechnologyArtificial Intelligence dynotx.com ↗

Company facts

Founded: 2018
Employees: 96
Headquarters: United States
Type: Private
Funding: Series A · $100M · 2021